日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

STAT1 and IL-7 as potential diagnostic biomarkers for distinguishing high-grade from low-grade serous ovarian cancer: a multi-cohort analysis

STAT1 和 IL-7 作为区分高级别和低级别浆液性卵巢癌的潜在诊断生物标志物：一项多队列分析

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1779912
Wu, Zhuna; Zhuang, Xuanxuan; Zhan, Xinxin; Chen, Weihong; Xie, Yajing; Zhou, Zhimei; Huang, Li; Sheng, Liying; Wang, Yueli; Chen, Binbin; Wu, Ruiyun; Ke, Yumin
卵巢癌
IL-7
JAK/STAT
STAT1
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Identification of the key immune and inflammatory related gene CALCRL as diagnostic biomarker in differentiating uterine leiomyosarcoma from leiomyoma

鉴定关键免疫和炎症相关基因CALCRL作为鉴别子宫平滑肌肉瘤和子宫平滑肌瘤的诊断生物标志物

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2026.1777897
Chen, Shiying; Wu, Zhuna; Yang, Congmei; Huang, Li; Xie, Yajing; Zhou, Zhimei; Sheng, Liying; Wang, Yueli; Chen, Binbin; Liu, Shunlan; Ke, Yumin
免疫/内分泌
炎症/感染
炎症
发表日期：2026
文献求助 收藏

GAL and F2R as immune diagnostic biomarkers for fetal growth restriction

GAL 和 F2R 作为胎儿生长受限的免疫诊断生物标志物

期刊:iScience
影响因子:4.1
doi:10.1016/j.isci.2026.115228
Chen, Shiying; Ke, Yumin; Zhou, Zhimei; Xie, Yajing; Chen, Weihong; Huang, Li; Sheng, Liying; Wang, Yueli; Chen, Binbin; Yang, Congmei; Wu, Zhuna
免疫/内分泌
发表日期：2026
文献求助 收藏

HLA-DPA1 as a diagnostic biomarker differentiating early- and late-onset preeclampsia

HLA-DPA1 作为区分早发型和晚发型子痫前期的诊断生物标志物

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-026-39050-0
Wu, Zhuna; Xie, Yajing; Chen, Weihong; Zhou, Zhimei; Huang, Li; Sheng, Liying; Wang, Yueli; Chen, Binbin; Yang, Congmei; Ke, Yumin
发表日期：2026
文献求助 收藏

LYN and CYBB are pivotal immune and inflammatory genes as diagnostic biomarkers in recurrent spontaneous abortion.

LYN 和 CYBB 是关键的免疫和炎症基因，可作为复发性自然流产的诊断生物标志物

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1568536
Wu Zhuna, Lin Qiuya, Zhou Zhimei, Xie Yajing, Huang Li, Sheng Liying, Shi Qirong, Ke Yumin
免疫/内分泌
炎症
发表日期：2025
文献求助 收藏

Identification of the key immune gene NR3C1 as a diagnostic biomarker in differentiating ovarian borderline tumors from benign tumors

鉴定关键免疫基因NR3C1作为鉴别卵巢交界性肿瘤与良性肿瘤的诊断生物标志物

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2025.1602192
Chen, Shiying; Ke, Yumin; Xie, Yajing; Zhou, Zhimei; Chen, Weihong; Huang, Li; Sheng, Liying; Wang, Yueli; Liu, Shunlan; Wu, Zhuna
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Research progress of ECT2 and RhoA-related signaling pathways in gynecological tumors

妇科肿瘤中ECT2和RhoA相关信号通路的研究进展

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2025.1602649
Sheng, Liying; Liang, Meili; Wang, Yueli; Zhou, Zhimei; Xie, Yajing; Ke, Yumin; Wu, Zhuna
ECT2
信号转导
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Recognition of pivotal immune genes NR1H4 and IL4R as diagnostic biomarkers in distinguishing ovarian clear cell cancer from high-grade serous cancer

NR1H4 和 IL4R 这两个关键免疫基因被确认为区分卵巢透明细胞癌和高级别浆液性癌的诊断生物标志物

期刊:Frontiers in Molecular Biosciences
影响因子:4
doi:10.3389/fmolb.2025.1600808
Ke, Yumin; Liang, Meili; Zhou, Zhimei; Xie, Yajing; Huang, Li; Sheng, Liying; Wang, Yueli; Zhou, Xinyan; Wu, Zhuna
免疫/内分泌
IL4
肿瘤
细胞生物学
肿瘤免疫
发表日期：2025
文献求助 收藏

Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer

使用小分子抑制剂选择性靶向 BCL6 是卵巢癌的潜在治疗策略

期刊:International Journal of Biological Sciences
影响因子:8.2
doi:10.7150/ijbs.86303
Min Wu, Jiuqing Xie, Yajing Xing, Lin Zhang, Huang Chen, Bin Tang, Miaoran Zhou, Shiyi Lv, Dongxia Huang, Shuyi Jian, Cili Zhou, Mingyao Liu, Weikai Guo, Yihua Chen, Zhengfang Yi
肿瘤
卵巢癌
发表日期：2024
文献求助 收藏

Advances in understanding the molecular mechanisms of borderline ovarian tumors

对交界性卵巢肿瘤分子机制认识的进展

期刊:Frontiers in Molecular Biosciences
影响因子:4
doi:10.3389/fmolb.2024.1429852
Chen, Shiying; Huang, Li; Liang, Meili; Xie, Yajing; Zhou, Zhimei; Ke, Yumin; Wu, Zhuna
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏